Literature DB >> 26203082

Fitness cost of antibiotic susceptibility during bacterial infection.

Damien Roux1, Olga Danilchanka2, Thomas Guillard3, Vincent Cattoir4, Hugues Aschard5, Yang Fu2, Francois Angoulvant6, Jonathan Messika7, Jean-Damien Ricard7, John J Mekalanos2, Stephen Lory2, Gerald B Pier8, David Skurnik8.   

Abstract

Advances in high-throughput DNA sequencing allow for a comprehensive analysis of bacterial genes that contribute to virulence in a specific infectious setting. Such information can yield new insights that affect decisions on how to best manage major public health issues such as the threat posed by increasing antimicrobial drug resistance. Much of the focus has been on the consequences of the selective advantage conferred on drug-resistant strains during antibiotic therapy. It is thought that the genetic and phenotypic changes that confer resistance also result in concomitant reductions in in vivo fitness, virulence, and transmission. However, experimental validation of this accepted paradigm is modest. Using a saturated transposon library of Pseudomonas aeruginosa, we identified genes across many functional categories and operons that contributed to maximal in vivo fitness during lung infections in animal models. Genes that bestowed both intrinsic and acquired antibiotic resistance provided a positive in vivo fitness advantage to P. aeruginosa during infection. We confirmed these findings in the pathogenic bacteria Acinetobacter baumannii and Vibrio cholerae using murine and rabbit infection models, respectively. Our results show that efforts to confront the worldwide increase in antibiotic resistance might be exacerbated by fitness advantages that enhance virulence in drug-resistant microbes.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26203082     DOI: 10.1126/scitranslmed.aab1621

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  52 in total

Review 1.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

2.  Iminoguanidines as Allosteric Inhibitors of the Iron-Regulated Heme Oxygenase (HemO) of Pseudomonas aeruginosa.

Authors:  Geoffrey A Heinzl; Weiliang Huang; Wenbo Yu; Bennett J Giardina; Yue Zhou; Alexander D MacKerell; Angela Wilks; Fengtian Xue
Journal:  J Med Chem       Date:  2016-07-11       Impact factor: 7.446

3.  Virulence gene profiles of Shigella species isolated from stool specimens in India: its association with clinical manifestation and antimicrobial resistance.

Authors:  Dhiviya Prabaa Muthuirulandi Sethuvel; Shalini Anandan; Joy Sarojini Michael; Dhivya Murugan; Ayyanraj Neeravi; Valsan Philip Verghese; Kamini Walia; Balaji Veeraraghavan
Journal:  Pathog Glob Health       Date:  2019-06-21       Impact factor: 2.894

Review 4.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 5.  Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.

Authors:  Edward Geisinger; Ralph R Isberg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

6.  Uncoupled Quorum Sensing Modulates the Interplay of Virulence and Resistance in a Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolate Belonging to the MLST550 Clonal Complex.

Authors:  Tingying Xia; Yanran Li; Zeling Xu; Huiluo Cao; Salim Bougouffa; Yat Kei Lo; Vladimir B Bajic; Haiwei Luo; Patrick C Y Woo; Aixin Yan
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

7.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

Review 8.  Understanding resistance.

Authors:  François Barbier; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2016-09-19       Impact factor: 17.440

9.  Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.

Authors:  David Skurnik; Olivier Clermont; Thomas Guillard; Adrien Launay; Olga Danilchanka; Stéphanie Pons; Laure Diancourt; François Lebreton; Kristina Kadlec; Damien Roux; Deming Jiang; Sara Dion; Hugues Aschard; Maurice Denamur; Colette Cywes-Bentley; Stefan Schwarz; Olivier Tenaillon; Antoine Andremont; Bertrand Picard; John Mekalanos; Sylvain Brisse; Erick Denamur
Journal:  Mol Biol Evol       Date:  2015-11-26       Impact factor: 16.240

10.  Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.

Authors:  Yanfang Feng; Martijs J Jonker; Ioannis Moustakas; Stanley Brul; Benno H Ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.